世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
幹細胞バンキング市場：細胞タイプ別（臍帯幹細胞、成体幹細胞、胚性幹細胞）、バンクタイプ別（プライベートバンク、パブリックバンク、ハイブリッドバンク）、用途別（サラセミア、脳性麻痺、糖尿病、白血病、自閉症）、地域別、2032年までの世界予測Stem Cell Banking Market based on By Cell Type (Umbilical Cord Stem Cells, Adult Stem Cells, Embryonic Stem Cells), By Bank Type (Private Banks, Public Banks, Hybrid Banks) and By Application (Thalassemia, Cerebral Palsy, Diabetes, Leukemia, Autism),Regional Outlook Global Forecast up to 2032 幹細胞バンクの医薬品としての可能性に対する認識の高まりが、市場のCAGRを牽引している。より多くの臨床エビデンスが入手可能になるにつれ、幹細胞治療の可能性に対する一般市民の認識も高まっている。さらに幹... もっと見る
サマリー幹細胞バンクの医薬品としての可能性に対する認識の高まりが、市場のCAGRを牽引している。より多くの臨床エビデンスが入手可能になるにつれ、幹細胞治療の可能性に対する一般市民の認識も高まっている。さらに幹細胞は、がん、変性神経筋疾患、代謝障害、免疫不全疾患、血友病など、80以上の病気や疾患を効果的に治療することが示されている。調査期間中、発展途上国の一人当たりの可処分所得が増加し続け、これらの治療に関連する製品のコストが低下するにつれて、幹細胞治療と幹細胞バンキング・サービスに対する一般市民の認識と採用が増加すると予想される。細胞バンクのアウトソーシング事業では、研究開発活動やバイオ医薬品の開発において、副作用を最小限に抑え、最大限の効果を保証するために、細胞、細胞株、組織の維持、収集、評価、特性評価が行われる。しかし、これらの細胞を細胞バンクに保管するための高額な費用は、この分野にとって大きなハードルとなっている。幹細胞バンクや他の種類の細胞バンクを取り巻くいくつかの法的な検討事項が、この事業の妨げになると予想される。細胞バンク構築の一つの段階は、細胞の慎重な凍結保存である。凍結される細胞株の生物学的性質、使用される凍結培地、そして凍結または凍結プロファイル技術は、凍結保存の質を決定する最も重要な3つの側面である。細胞バンクの規模は、凍結保存の質に大きな影響を与える。なぜなら、規模の大小にかかわらず、温度変化、取り扱いの特異性、タイミングのばらつきなどにより、バイアル間のばらつきが大きくなる可能性があるからである。幹細胞治療に対する需要の高まりは、市場拡大の主な要因の一つである。細胞治療、再生医療、創薬、毒性、発生生物学研究における幹細胞の応用は、その生物学的特性を維持し、汚染や劣化を防ぎ、基礎研究やトランスレーショナル研究、現在および将来の治療応用における効果的な使用を可能にするため、非常に有望である。 目次1. Executive Summary2. Industry Outlook 2.1. Industry Overview 2.2. Industry Trends 3. Market Snapshot 3.1. Market Definition 3.2. Market Outlook 3.2.1. Porter Five Forces 3.3. Related Markets 4. Market characteristics 4.1. Market Overview 4.2. Market Segmentation 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. DRO - Impact Analysis 5. Cell type: Market Size & Analysis 5.1. Overview 5.2. Umbilical Cord Stem Cells 5.3. Adult Stem Cells 5.4. Embryonic Stem Cells 6. Bank type: Market Size & Analysis 6.1. Overview 6.2. Private Banks 6.3. Public Banks 6.4. Hybrid Banks 7. Application: Market Size & Analysis 7.1. Overview 7.2. Thalassemia 7.3. Cerebral Palsy 7.4. Diabetes 7.5. Leukemia 7.6. Autism 8. Geography: Market Size & Analysis 8.1. Overview 8.2. North America (U.S., Mexico, Canada) 8.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe) 8.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC) 8.5. Latin America (Brazil, Argentina) 8.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa) 9. Competitive Landscape 9.1. Competitor Comparison Analysis 9.2. Market Developments 9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships 9.2.2. Product Launches and execution 10. Vendor Profiles 10.1. TRINA SOLAR (CHINA) 10.1.1. Overview 10.1.2. Financial Overview 10.1.3. Product Offerings 10.1.4. Developments 10.1.5. Business Strategy 10.2. FIRST SOLAR (U.S.) 10.2.1. Overview 10.2.2. Financial Overview 10.2.3. Product Offerings 10.2.4. Developments 10.2.5. Business Strategy 10.3. YINGLI SOLAR (CHINA) 10.3.1. Overview 10.3.2. Financial Overview 10.3.3. Product Offerings 10.3.4. Developments 10.3.5. Business Strategy 10.4. TATA POWER SOLAR SYSTEM LTD (INDIA) 10.4.1. Overview 10.4.2. Financial Overview 10.4.3. Product Offerings 10.4.4. Developments 10.4.5. Business Strategy 10.5. ABENGOA (SPAIN) 10.5.1. Overview 10.5.2. Financial Overview 10.5.3. Product Offerings 10.5.4. Developments 10.5.5. Business Strategy 10.6. CANADIAN SOLAR INC. (CANADA) 10.6.1. Overview 10.6.2. Financial Overview 10.6.3. Product Offerings 10.6.4. Developments 10.6.5. Business Strategy 10.7. WAAREE GROUP (INDIA) 10.7.1. Overview 10.7.2. Financial Overview 10.7.3. Product Offerings 10.7.4. Developments 10.7.5. Business Strategy 10.8. GENERAL ELECTRIC COMPANY (U.S.) 10.8.1. Overview 10.8.2. Financial Overview 10.8.3. Product Offerings 10.8.4. Developments 10.8.5. Business Strategy 10.9. SUNPOWER CORPORATION (U.S.) 10.9.1. Overview 10.9.2. Financial Overview 10.9.3. Product Offerings 10.9.4. Developments 10.9.5. Business Strategy 10.10. URJA GLOBAL LIMITED (INDIA) 10.10.1. Overview 10.10.2. Financial Overview 10.10.3. Product Offerings 10.10.4. Developments 10.10.5. Business Strategy 11. Analyst Opinion 12. Annexure 図表リストTABLE 1. STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION)TABLE 2. STEM CELL BANKING MARKET VALUE FOR UMBILICAL CORD STEM CELLS, BY GEOGRAPHY , 2021-2030 (USD BILLION) TABLE 3. STEM CELL BANKING MARKET VALUE FOR ADULT STEM CELLS, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 4. STEM CELL BANKING MARKET VALUE FOR EMBRYONIC STEM CELLS, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 5. STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 6. STEM CELL BANKING MARKET VALUE FOR PRIVATE BANKS, 2021-2030 (USD BILLION) TABLE 7. STEM CELL BANKING MARKET VALUE FOR PUBLIC BANKS, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 8. STEM CELL BANKING MARKET VALUE FOR HYBRID BANKS, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 9. STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 10. STEM CELL BANKING MARKET VALUE FOR THALASSEMIA, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 11. STEM CELL BANKING MARKET VALUE FOR CEREBRAL PALSY, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 12. STEM CELL BANKING MARKET VALUE FOR DIABETES, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 13. STEM CELL BANKING MARKET VALUE FOR LEUKEMIA, 2021-2030 (USD BILLION) TABLE 14. STEM CELL BANKING MARKET VALUE FOR AUTISM, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 15. NORTH AMERICA STEM CELL BANKING MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION) TABLE 16. NORTH AMERICA STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 17. NORTH AMERICA STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 18. NORTH AMERICA STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 19. U.S STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 20. U.S STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 21. U.S STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 22. CANADA STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 23. CANADA STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 24. CANADA STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 25. MEXICO STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 26. MEXICO STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 27. MEXICO STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 28. EUROPE STEM CELL BANKING MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION) TABLE 29. EUROPE STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 30. EUROPE STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 31. EUROPE STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 32. GERMANY STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 33. GERMANY STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 34. GERMANY STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 35. U.K STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 36. U.K STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 37. U.K STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 38. FRANCE STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 39. FRANCE STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 40. FRANCE STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 41. ITALY STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 42. ITALY STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 43. ITALY STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 44. SPAIN STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 45. SPAIN STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 46. SPAIN STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 47. ROE STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 48. ROE STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 49. ROE STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 50. ASIA PACIFIC STEM CELL BANKING MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION) TABLE 51. ASIA PACIFIC STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 52. ASIA PACIFIC STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 53. ASIA PACIFIC STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 54. CHINA STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 55. CHINA STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 56. CHINA STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 57. INDIA STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 58. INDIA STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 59. INDIA STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 60. JAPAN STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 61. JAPAN STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 62. JAPAN STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 63. REST OF APAC STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 64. REST OF APAC STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 65. REST OF APAC STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 66. LATIN AMERICA STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 67. LATIN AMERICA STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 68. LATIN AMERICA STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 69. BRAZIL STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 70. BRAZIL STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 71. BRAZIL STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 72. ARGENTINA STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 73. ARGENTINA STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 74. ARGENTINA STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 75. MIDDLE EAST AND AFRICA STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 76. MIDDLE EAST AND AFRICA STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 77. MIDDLE EAST AND AFRICA STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 78. SAUDI ARABIA STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 79. SAUDI ARABIA STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 80. SAUDI ARABIA STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 81. UAE STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 82. UAE STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 83. UAE STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 84. REST OF MIDDLE EAST AND AFRICA STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 85. REST OF MIDDLE EAST AND AFRICA STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 86. REST OF MIDDLE EAST AND AFRICA STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 87. TRINA SOLAR (CHINA) : FINANCIALS TABLE 88. TRINA SOLAR (CHINA) : PRODUCTS & SERVICES TABLE 89. TRINA SOLAR (CHINA) : RECENT DEVELOPMENTS TABLE 90. FIRST SOLAR (U.S.): FINANCIALS TABLE 91. FIRST SOLAR (U.S.): PRODUCTS & SERVICES TABLE 92. FIRST SOLAR (U.S.): RECENT DEVELOPMENTS TABLE 93. YINGLI SOLAR (CHINA): FINANCIALS TABLE 94. YINGLI SOLAR (CHINA): PRODUCTS & SERVICES TABLE 95. YINGLI SOLAR (CHINA): RECENT DEVELOPMENTS TABLE 96. TATA POWER SOLAR SYSTEM LTD (INDIA): FINANCIALS TABLE 97. TATA POWER SOLAR SYSTEM LTD (INDIA): PRODUCTS & SERVICES TABLE 98. TATA POWER SOLAR SYSTEM LTD (INDIA): RECENT DEVELOPMENTS TABLE 99. ABENGOA (SPAIN): FINANCIALS TABLE 100. ABENGOA (SPAIN): PRODUCTS & SERVICES TABLE 101. ABENGOA (SPAIN): RECENT DEVELOPMENTS TABLE 102. CANADIAN SOLAR INC. (CANADA): FINANCIALS TABLE 103. CANADIAN SOLAR INC. (CANADA): PRODUCTS & SERVICES TABLE 104. CANADIAN SOLAR INC. (CANADA): RECENT DEVELOPMENTS TABLE 105. WAAREE GROUP (INDIA): FINANCIALS TABLE 106. WAAREE GROUP (INDIA): PRODUCTS & SERVICES TABLE 107. WAAREE GROUP (INDIA): DEVELOPMENTS TABLE 108. GENERAL ELECTRIC COMPANY (U.S.): FINANCIALS TABLE 109. GENERAL ELECTRIC COMPANY (U.S.): PRODUCTS & SERVICES TABLE 110. GENERAL ELECTRIC COMPANY (U.S.): RECENT DEVELOPMENTS TABLE 111. SUNPOWER CORPORATION (U.S.): FINANCIALS TABLE 112. SUNPOWER CORPORATION (U.S.): PRODUCTS & SERVICES TABLE 113. SUNPOWER CORPORATION (U.S.): RECENT DEVELOPMENTS TABLE 114. URJA GLOBAL LIMITED (INDIA): FINANCIALS TABLE 115. URJA GLOBAL LIMITED (INDIA): PRODUCTS & SERVICES TABLE 116. URJA GLOBAL LIMITED (INDIA): RECENT DEVELOPMENTS プレスリリース
幹細胞バンキング市場：動向と予測-2022-2030年
"2022年の幹細胞バンキング市場は51億米ドルと推定される。幹細胞バンキング市場は、2023年の58.7億米ドルから2032年には180.8億米ドルに拡大し、2023年から2032年の年間平均成長率（CAGR）は15.8%になると予測される。市場拡大を後押しする主な市場要因としては、慢性疾患の罹患率の上昇や生命を脅かす遺伝子異常などが挙げられる。 要点 - 本レポートは、幹細胞バンキング市場を牽引し、機会を提供している最も重要な属性を示しています。 - この調査レポートは、幹細胞バンキング市場の成長を市場のいくつかのセグメントに基づいて詳細に分析します。 - 幹細胞バンキング市場の過去と現在の動向予測を提示します。 - また、幹細胞バンキング市場の主要企業の主要戦略や能力などの競争分析も提示しています。 Infoholic Research社について Infoholic Research社は、世界的な市場調査・コンサルティング機関です。新興のニッチ技術や市場のマーケットインテリジェンスを提供しています。厳格な方法論と質の高い指標を駆使した市場分析により、新興市場、新興技術、新興ビジネスモデルに関する情報と予測を提供します。業種や国別レポートに深くフォーカスすることで、お客様がビジネスチャンスを見極め、ビジネス戦略を策定するお手伝いをします。 連絡先 プレス・メディア連絡先 バスカール・ジョティ・ナス インフォホリック・リサーチLLP +91-80-22222833, +91-8867685927 bhaskar@infoholicresearch.com 電話番号080 411 411 05 電子メール：us.inquiry@infoholicresearch.com
SummaryThe increased awareness of stem cell banking's medicinal potential is driving the market CAGR. As more clinical evidence becomes accessible, public awareness of stem cell therapeutic potential grows. Furthermore, stem cells have been shown to effectively cure over 80 illnesses and ailments, including cancer, degenerative neuromuscular disorders, metabolic disorders, immune deficiency diseases, and haemophilia. During the study period, it is expected that public awareness and adoption of stem cell therapies and stem cell banking services will increase as per capita disposable income in developing countries continues to rise and the costs of the products associated with these treatments fall. In the cell banking outsourcing business, cells, cell lines, and tissues are maintained, collected, evaluated, and characterised to guarantee minimal adverse effects and maximum efficacy while developing R&D activities and biopharmaceuticals. However, the costly expense of keeping these cells in cell banks is a significant hurdle for this sector. Several legal considerations surrounding stem cell banking and other kinds of cell banking are expected to hinder the business. Table of Contents1. Executive Summary2. Industry Outlook 2.1. Industry Overview 2.2. Industry Trends 3. Market Snapshot 3.1. Market Definition 3.2. Market Outlook 3.2.1. Porter Five Forces 3.3. Related Markets 4. Market characteristics 4.1. Market Overview 4.2. Market Segmentation 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. DRO - Impact Analysis 5. Cell type: Market Size & Analysis 5.1. Overview 5.2. Umbilical Cord Stem Cells 5.3. Adult Stem Cells 5.4. Embryonic Stem Cells 6. Bank type: Market Size & Analysis 6.1. Overview 6.2. Private Banks 6.3. Public Banks 6.4. Hybrid Banks 7. Application: Market Size & Analysis 7.1. Overview 7.2. Thalassemia 7.3. Cerebral Palsy 7.4. Diabetes 7.5. Leukemia 7.6. Autism 8. Geography: Market Size & Analysis 8.1. Overview 8.2. North America (U.S., Mexico, Canada) 8.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe) 8.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC) 8.5. Latin America (Brazil, Argentina) 8.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa) 9. Competitive Landscape 9.1. Competitor Comparison Analysis 9.2. Market Developments 9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships 9.2.2. Product Launches and execution 10. Vendor Profiles 10.1. TRINA SOLAR (CHINA) 10.1.1. Overview 10.1.2. Financial Overview 10.1.3. Product Offerings 10.1.4. Developments 10.1.5. Business Strategy 10.2. FIRST SOLAR (U.S.) 10.2.1. Overview 10.2.2. Financial Overview 10.2.3. Product Offerings 10.2.4. Developments 10.2.5. Business Strategy 10.3. YINGLI SOLAR (CHINA) 10.3.1. Overview 10.3.2. Financial Overview 10.3.3. Product Offerings 10.3.4. Developments 10.3.5. Business Strategy 10.4. TATA POWER SOLAR SYSTEM LTD (INDIA) 10.4.1. Overview 10.4.2. Financial Overview 10.4.3. Product Offerings 10.4.4. Developments 10.4.5. Business Strategy 10.5. ABENGOA (SPAIN) 10.5.1. Overview 10.5.2. Financial Overview 10.5.3. Product Offerings 10.5.4. Developments 10.5.5. Business Strategy 10.6. CANADIAN SOLAR INC. (CANADA) 10.6.1. Overview 10.6.2. Financial Overview 10.6.3. Product Offerings 10.6.4. Developments 10.6.5. Business Strategy 10.7. WAAREE GROUP (INDIA) 10.7.1. Overview 10.7.2. Financial Overview 10.7.3. Product Offerings 10.7.4. Developments 10.7.5. Business Strategy 10.8. GENERAL ELECTRIC COMPANY (U.S.) 10.8.1. Overview 10.8.2. Financial Overview 10.8.3. Product Offerings 10.8.4. Developments 10.8.5. Business Strategy 10.9. SUNPOWER CORPORATION (U.S.) 10.9.1. Overview 10.9.2. Financial Overview 10.9.3. Product Offerings 10.9.4. Developments 10.9.5. Business Strategy 10.10. URJA GLOBAL LIMITED (INDIA) 10.10.1. Overview 10.10.2. Financial Overview 10.10.3. Product Offerings 10.10.4. Developments 10.10.5. Business Strategy 11. Analyst Opinion 12. Annexure List of Tables/GraphsTABLE 1. STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION)TABLE 2. STEM CELL BANKING MARKET VALUE FOR UMBILICAL CORD STEM CELLS, BY GEOGRAPHY , 2021-2030 (USD BILLION) TABLE 3. STEM CELL BANKING MARKET VALUE FOR ADULT STEM CELLS, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 4. STEM CELL BANKING MARKET VALUE FOR EMBRYONIC STEM CELLS, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 5. STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 6. STEM CELL BANKING MARKET VALUE FOR PRIVATE BANKS, 2021-2030 (USD BILLION) TABLE 7. STEM CELL BANKING MARKET VALUE FOR PUBLIC BANKS, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 8. STEM CELL BANKING MARKET VALUE FOR HYBRID BANKS, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 9. STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 10. STEM CELL BANKING MARKET VALUE FOR THALASSEMIA, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 11. STEM CELL BANKING MARKET VALUE FOR CEREBRAL PALSY, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 12. STEM CELL BANKING MARKET VALUE FOR DIABETES, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 13. STEM CELL BANKING MARKET VALUE FOR LEUKEMIA, 2021-2030 (USD BILLION) TABLE 14. STEM CELL BANKING MARKET VALUE FOR AUTISM, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 15. NORTH AMERICA STEM CELL BANKING MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION) TABLE 16. NORTH AMERICA STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 17. NORTH AMERICA STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 18. NORTH AMERICA STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 19. U.S STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 20. U.S STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 21. U.S STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 22. CANADA STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 23. CANADA STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 24. CANADA STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 25. MEXICO STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 26. MEXICO STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 27. MEXICO STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 28. EUROPE STEM CELL BANKING MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION) TABLE 29. EUROPE STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 30. EUROPE STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 31. EUROPE STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 32. GERMANY STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 33. GERMANY STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 34. GERMANY STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 35. U.K STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 36. U.K STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 37. U.K STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 38. FRANCE STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 39. FRANCE STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 40. FRANCE STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 41. ITALY STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 42. ITALY STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 43. ITALY STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 44. SPAIN STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 45. SPAIN STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 46. SPAIN STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 47. ROE STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 48. ROE STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 49. ROE STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 50. ASIA PACIFIC STEM CELL BANKING MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION) TABLE 51. ASIA PACIFIC STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 52. ASIA PACIFIC STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 53. ASIA PACIFIC STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 54. CHINA STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 55. CHINA STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 56. CHINA STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 57. INDIA STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 58. INDIA STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 59. INDIA STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 60. JAPAN STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 61. JAPAN STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 62. JAPAN STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 63. REST OF APAC STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 64. REST OF APAC STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 65. REST OF APAC STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 66. LATIN AMERICA STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 67. LATIN AMERICA STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 68. LATIN AMERICA STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 69. BRAZIL STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 70. BRAZIL STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 71. BRAZIL STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 72. ARGENTINA STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 73. ARGENTINA STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 74. ARGENTINA STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 75. MIDDLE EAST AND AFRICA STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 76. MIDDLE EAST AND AFRICA STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 77. MIDDLE EAST AND AFRICA STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 78. SAUDI ARABIA STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 79. SAUDI ARABIA STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 80. SAUDI ARABIA STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 81. UAE STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 82. UAE STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 83. UAE STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 84. REST OF MIDDLE EAST AND AFRICA STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION) TABLE 85. REST OF MIDDLE EAST AND AFRICA STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION) TABLE 86. REST OF MIDDLE EAST AND AFRICA STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 87. TRINA SOLAR (CHINA) : FINANCIALS TABLE 88. TRINA SOLAR (CHINA) : PRODUCTS & SERVICES TABLE 89. TRINA SOLAR (CHINA) : RECENT DEVELOPMENTS TABLE 90. FIRST SOLAR (U.S.): FINANCIALS TABLE 91. FIRST SOLAR (U.S.): PRODUCTS & SERVICES TABLE 92. FIRST SOLAR (U.S.): RECENT DEVELOPMENTS TABLE 93. YINGLI SOLAR (CHINA): FINANCIALS TABLE 94. YINGLI SOLAR (CHINA): PRODUCTS & SERVICES TABLE 95. YINGLI SOLAR (CHINA): RECENT DEVELOPMENTS TABLE 96. TATA POWER SOLAR SYSTEM LTD (INDIA): FINANCIALS TABLE 97. TATA POWER SOLAR SYSTEM LTD (INDIA): PRODUCTS & SERVICES TABLE 98. TATA POWER SOLAR SYSTEM LTD (INDIA): RECENT DEVELOPMENTS TABLE 99. ABENGOA (SPAIN): FINANCIALS TABLE 100. ABENGOA (SPAIN): PRODUCTS & SERVICES TABLE 101. ABENGOA (SPAIN): RECENT DEVELOPMENTS TABLE 102. CANADIAN SOLAR INC. (CANADA): FINANCIALS TABLE 103. CANADIAN SOLAR INC. (CANADA): PRODUCTS & SERVICES TABLE 104. CANADIAN SOLAR INC. (CANADA): RECENT DEVELOPMENTS TABLE 105. WAAREE GROUP (INDIA): FINANCIALS TABLE 106. WAAREE GROUP (INDIA): PRODUCTS & SERVICES TABLE 107. WAAREE GROUP (INDIA): DEVELOPMENTS TABLE 108. GENERAL ELECTRIC COMPANY (U.S.): FINANCIALS TABLE 109. GENERAL ELECTRIC COMPANY (U.S.): PRODUCTS & SERVICES TABLE 110. GENERAL ELECTRIC COMPANY (U.S.): RECENT DEVELOPMENTS TABLE 111. SUNPOWER CORPORATION (U.S.): FINANCIALS TABLE 112. SUNPOWER CORPORATION (U.S.): PRODUCTS & SERVICES TABLE 113. SUNPOWER CORPORATION (U.S.): RECENT DEVELOPMENTS TABLE 114. URJA GLOBAL LIMITED (INDIA): FINANCIALS TABLE 115. URJA GLOBAL LIMITED (INDIA): PRODUCTS & SERVICES TABLE 116. URJA GLOBAL LIMITED (INDIA): RECENT DEVELOPMENTS Press ReleaseStem Cell Banking Market : Trends & Forecast – 2022-2030
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療）の最新刊レポート
IHR Insights社の医療分野での最新刊レポート
本レポートと同じKEY WORD（stem cell）の最新刊レポート
よくあるご質問IHR Insights社はどのような調査会社ですか?IHR InsightsはICT、化学品、ヘルスケア、半導体など、世界の幅広い分野を対象に調査し、専門的な知識を基に市場調査報告書を出版しています。 主な調査分野 ◇ICT ◇化学品、材料、... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
